{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:47:46Z","timestamp":1794934066672,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Japan Society for Promotion of Science KAKENHI","award":["21K08541"],"award-info":[{"award-number":["21K08541"]}]},{"name":"The Japan Society for Promotion of Science KAKENHI","award":["15K09406"],"award-info":[{"award-number":["15K09406"]}]},{"name":"Mr. Yasuyuki Yokoyama"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In slowly progressive type 1 diabetes mellitus (SPIDDM), the pancreas shows sustained islet inflammation, pancreatitis, pancreatic acinar cell metaplasia\/dysplasia (ADM), and intraepithelial neoplasia (PanIN), a precancerous lesion. The mechanisms underlying these changes remain unclear. The presence of enterovirus (EV) encoded-capsid protein 1 (VP1) and -2A protease (2A\n                    <jats:sup>pro<\/jats:sup>\n                    ) and the innate immune responses of the pancreas were studied using immunohistochemistry and in situ hybridization in 12 SPIDDM and 19 non-diabetic control pancreases. VP1, 2A\n                    <jats:sup>pro<\/jats:sup>\n                    , and EV-RNA were detected in islets and the exocrine pancreas in all SPIDDM pancreases. Innate immune receptor, melanoma differentiation-associated gene 5 (MDA5), and interferon (IFN)-beta1 were intensified in the islets of SPIDDM patients with short disease duration. However, expressions of MDA5 and IFN-beta1were suppressed in those with longer disease duration. CD3\n                    <jats:sup>+<\/jats:sup>\n                    T cell infiltration was observed in the VP1- and insulin-positive islets (insulitis) and exocrine acinar cells. CD11c\n                    <jats:sup>+<\/jats:sup>\n                    dendritic cells (DCs) in islets were scarce in long-term SPIDDM. This study showed the consistent presence of EV, suggesting an association with inflammatory changes in the endocrine and exocrine pancreas in SPIDDM. Suppressed expressions of MDA5 and IFN-beta1, as well as decreased numbers of DCs in the host cells, may contribute to persistent EV infection and induction of ADM\/PanIN lesions, which may potentially provide a scaffold for pancreatic neoplasms.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-33011-7","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T08:03:09Z","timestamp":1682668989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-008X","authenticated-orcid":false,"given":"Tomoyasu","family":"Fukui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4364-2527","authenticated-orcid":false,"given":"Tetsuro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Aida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-4983","authenticated-orcid":false,"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-6751","authenticated-orcid":false,"given":"Yoichi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-1183","authenticated-orcid":false,"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5454-2660","authenticated-orcid":false,"given":"Rikako","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-2975","authenticated-orcid":false,"given":"Kazuhiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-9055","authenticated-orcid":false,"given":"Akira","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4255-774X","authenticated-orcid":false,"given":"Soroku","family":"Yagihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"33011_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diab.36.4.510","volume":"36","author":"T Kobayashi","year":"1987","unstructured":"Kobayashi, T., Itoh, T., Kosaka, K. & Sato, K. Time course of islet cell antibodies and \u03b2-cell function in non\u2013insulin-dependent stage of type I diabetes. Diabetes 36, 510\u2013517. https:\/\/doi.org\/10.2337\/diab.36.4.510 (1987).","journal-title":"Diabetes"},{"key":"33011_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2337\/diacare.12.1.7","volume":"12","author":"T Kobayashi","year":"1989","unstructured":"Kobayashi, T. et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care 12, 7\u201311. https:\/\/doi.org\/10.2337\/diacare.12.1.7 (1989).","journal-title":"Diabetes Care"},{"key":"33011_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/diacare.16.5.780","volume":"16","author":"T Kobayashi","year":"1993","unstructured":"Kobayashi, T. et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16, 780\u2013788. https:\/\/doi.org\/10.2337\/diacare.16.5.780 (1993).","journal-title":"Diabetes Care"},{"issue":"suppl","key":"33011_CR4","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/0168-8227(94)90234-8","volume":"24","author":"T Kobayashi","year":"1994","unstructured":"Kobayashi, T. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: Slowly progressive IDDM\u2014The clinical characteristics and pathogenesis of the syndrome. Diabetes Res. Clin. Pract. 24(suppl), S95\u2013S99. https:\/\/doi.org\/10.1016\/0168-8227(94)90234-8 (1994).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"suppl 2","key":"33011_CR5","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2337\/diabetes.54.suppl_2.S68","volume":"54","author":"G Stenstr\u00f6m","year":"2005","unstructured":"Stenstr\u00f6m, G., Gotts\u00e4ter, A., Bakhtadze, E., Berger, B. & Sundkvist, G. Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(suppl 2), S68\u2013S72. https:\/\/doi.org\/10.2337\/diabetes.54.suppl_2.S68 (2005).","journal-title":"Diabetes"},{"key":"33011_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00125-015-3789-z","volume":"59","author":"RD Leslie","year":"2016","unstructured":"Leslie, R. D., Palmer, J., Schloot, N. C. & Lemmar, A. Diabetes at the crossroads relevance of disease classification to pathophysiology and treatment. Diabetologia 59, 13\u201320. https:\/\/doi.org\/10.1007\/s00125-015-3789-z (2016).","journal-title":"Diabetologia"},{"key":"33011_CR7","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2147\/DMSO.S191007","volume":"12","author":"A Nishimura","year":"2019","unstructured":"Nishimura, A. et al. Slowly progressive type 1 diabetes mellitus: Current knowledge and future perspectives. Diabetes Metab. Syndr. Obes. 12, 2461\u20132477. https:\/\/doi.org\/10.2147\/DMSO.S191007 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"33011_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2337\/diacare.19.9.1031a","volume":"19","author":"T Kobayashi","year":"1996","unstructured":"Kobayashi, T., Nakanishi, K., Okubo, M., Murase, T. & Kosaka, K. GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care 19, 1031. https:\/\/doi.org\/10.2337\/diacare.19.9.1031a (1996).","journal-title":"Diabetes Care"},{"key":"33011_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13340-014-0199-2","volume":"6","author":"S Tanaka","year":"2015","unstructured":"Tanaka, S. et al. Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus of the Japan Diabetes Society. Diabetol. Int. 6, 1\u20137. https:\/\/doi.org\/10.1007\/s13340-014-0199-2 (2015).","journal-title":"Diabetol. Int."},{"key":"33011_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00125-016-3867-x","volume":"59","author":"T Kobayashi","year":"2016","unstructured":"Kobayashi, T. et al. Pancreatic ductal hyperplasia\/dysplasia with obstructive chronic pancreatitis: An association with reduced pancreatic weight in type 1 diabetes. Diabetologia 59, 865\u2013867. https:\/\/doi.org\/10.1007\/s00125-016-3867-x (2016).","journal-title":"Diabetologia"},{"key":"33011_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/MPA.0000000000001144","volume":"47","author":"K Aida","year":"2018","unstructured":"Aida, K. et al. Distinct inflammatory changes of the pancreas of slowly progressive insulin-dependent (type 1) diabetes. Pancreas 47, 1101\u20131109. https:\/\/doi.org\/10.1097\/MPA.0000000000001144 (2018).","journal-title":"Pancreas"},{"key":"33011_CR12","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk, O. et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am. J. Surg. Pathol. 39, 1730\u20131741. https:\/\/doi.org\/10.1097\/PAS.0000000000000533 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"33011_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/apc.2019.06.03","volume":"2","author":"Y Xu","year":"2019","unstructured":"Xu, Y., Liu, J., Nipper, M. & Wang, P. Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma. Ann. Pancreat. Cancer 2, 1\u201312. https:\/\/doi.org\/10.21037\/apc.2019.06.03 (2019).","journal-title":"Ann. Pancreat. Cancer"},{"key":"33011_CR14","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1172\/JCI57131","volume":"121","author":"M Reichert","year":"2014","unstructured":"Reichert, M. & Rustgi, A. K. Pancreatic ductal cells in development, regeneration, and neoplasia. J. Clin. Invest. 121, 4572\u20134578. https:\/\/doi.org\/10.1172\/JCI57131 (2014).","journal-title":"J. Clin. Invest."},{"key":"33011_CR15","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1210\/jc.2018-02672","volume":"104","author":"M Takita","year":"2019","unstructured":"Takita, M. et al. Unique inflammatory changes in exocrine and endocrine pancreas in enterovirus-induces fulminant type 1 diabetes. J. Clin. Endocrinol. Metab. 104, 4282\u20134294. https:\/\/doi.org\/10.1210\/jc.2018-02672 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5925","key":"33011_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1167728","volume":"324","author":"S Nejentsev","year":"2009","unstructured":"Nejentsev, S. et al. Rare variants of\u00a0IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324(5925), 387\u2013389. https:\/\/doi.org\/10.1126\/science.1167728 (2009).","journal-title":"Science"},{"issue":"1","key":"33011_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AG Dias Junior","year":"2019","unstructured":"Dias Junior, A. G., Sampaio, N. G. & Rehwinkel, J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol. 27(1), 75\u201385. https:\/\/doi.org\/10.1016\/j.tim.2018.08.007 (2019).","journal-title":"Trends Microbiol."},{"key":"33011_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/rmv.1883","volume":"26","author":"OH Laitinen","year":"2016","unstructured":"Laitinen, O. H. et al. Enteroviral proteases: Structure, host interactions and pathogenicity. Rev. Med. Virol. 26, 251\u2013267. https:\/\/doi.org\/10.1002\/rmv.1883 (2016).","journal-title":"Rev. Med. Virol."},{"key":"33011_CR19","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1128\/JVI.02712-13","volume":"88","author":"Q Feng","year":"2014","unstructured":"Feng, Q. et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 88, 3369\u20133378. https:\/\/doi.org\/10.1128\/JVI.02712-13 (2014).","journal-title":"J. Virol."},{"key":"33011_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","volume":"39","author":"A Waisman","year":"2017","unstructured":"Waisman, A., Lukas, D., Clausen, B. E. & Yogev, N. Dendritic cells as gatekeepers of tolerance. Semin. Immunopathol. 39, 153\u2013163. https:\/\/doi.org\/10.1007\/s00281-016-0583-z (2017).","journal-title":"Semin. Immunopathol."},{"key":"33011_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.semcdb.2015.03.011","volume":"41","author":"A Schlitzer","year":"2015","unstructured":"Schlitzer, A., McGovern, N. & Ginhoux, F. Dendritic cells and monocyte-derived cells: Two complementary and integrated functional systems. Semin. Cell Dev. Biol. 41, 9\u201322. https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.011 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"33011_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.virol.2012.04.005","volume":"429","author":"CC Kemball","year":"2012","unstructured":"Kemball, C. C., Flynn, C. T., Hosking, M. P., Botten, J. & Whitton, J. L. Wild type Coxsackievirus infection dramatically alters the abundance, heterogeneity, and immune-stimulatory capacity of conventional dendritic cells in vivo. Virology 429, 74\u201390. https:\/\/doi.org\/10.1016\/j.virol.2012.04.005 (2012).","journal-title":"Virology"},{"key":"33011_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/459347","author":"M Oikarinen","year":"2018","unstructured":"Oikarinen, M. et al. Detection of enterovirus protein and RNA in multiple tissue from nPOD organ donors with type 1 diabetes. bioRxiv. https:\/\/doi.org\/10.1101\/459347 (2018).","journal-title":"bioRxiv."},{"key":"33011_CR24","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00125-014-3340-7","volume":"57","author":"DA Schneider","year":"2014","unstructured":"Schneider, D. A. & von Herrath, M. G. Potential viral pathogenic mechanism in human type 1 diabetes. Diabetologia 57, 2009\u20132018. https:\/\/doi.org\/10.1007\/s00125-014-3340-7 (2014).","journal-title":"Diabetologia"},{"key":"33011_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-med-042320-015952","volume":"73","author":"RE Lloyd","year":"2022","unstructured":"Lloyd, R. E., Tamhankar, M. & Lernmark, \u00c5. Enteroviruses and type 1 diabetes: Multiple mechanisms and factors?. Annu. Rev. Med. 73, 483\u2013499. https:\/\/doi.org\/10.1146\/annurev-med-042320-015952 (2022).","journal-title":"Annu. Rev. Med."},{"key":"33011_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0140-6736(80)90349-9","volume":"316","author":"AB Jenson","year":"1980","unstructured":"Jenson, A. B., Rosenber, H. S. & Notkins, A. L. Pancreatic islet-cell damage in children with fatal viral infections. Lancet 316, 354\u2013358. https:\/\/doi.org\/10.1016\/S0140-6736(80)90349-9 (1980).","journal-title":"Lancet"},{"key":"33011_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF00403323","volume":"33","author":"AK Foulis","year":"1990","unstructured":"Foulis, A. K. et al. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin- dependent) diabetes and pancreases and hearts of infants who dies of coxsackieviral myocarditis. Diabetologia 33, 290\u2013298. https:\/\/doi.org\/10.1007\/BF00403323 (1990).","journal-title":"Diabetologia"},{"key":"33011_CR28","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00125-009-1276-0","volume":"52","author":"SJ Richardson","year":"2009","unstructured":"Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K. & Morgan, N. G. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52, 1143\u20131151. https:\/\/doi.org\/10.1007\/s00125-009-1276-0 (2009).","journal-title":"Diabetologia"},{"key":"33011_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00125-003-1297-z","volume":"47","author":"P Ylipaasto","year":"2004","unstructured":"Ylipaasto, P. et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47, 225\u2013239. https:\/\/doi.org\/10.1007\/s00125-003-1297-z (2004).","journal-title":"Diabetologia"},{"key":"33011_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrc.2017.68","volume":"17","author":"V Giroux","year":"2017","unstructured":"Giroux, V. & Rustgi, A. K. Metaplasia: Tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat. Rev. Cancer 17, 594\u2013604. https:\/\/doi.org\/10.1038\/nrc.2017.68 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"33011_CR31","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1161\/CIRCULATIONAHA.118.035966","volume":"139","author":"A Bouin","year":"2019","unstructured":"Bouin, A. et al. Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5\u2019 terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities. Circulation 139, 2326\u20132338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035966 (2019).","journal-title":"Circulation"},{"key":"33011_CR32","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1128\/JVI.78.15.8229-8237.2004","volume":"78","author":"SE Ostrowski","year":"2004","unstructured":"Ostrowski, S. E., Reilly, A. A., Collins, D. N. & Ramsingh, A. Progression or resolution of Coxsackievirus B4-inducced pancreatitis a genomic analysis: Progression or resolution of coxsackievirus B-4 induce pancreatitis a genomic analysis. J. Virol. 78, 8229\u20138237. https:\/\/doi.org\/10.1128\/JVI.78.15.8229-8237.2004 (2004).","journal-title":"J. Virol."},{"key":"33011_CR33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.24.3.510","volume":"24","author":"A Shimada","year":"2001","unstructured":"Shimada, A. et al. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24, 510\u2013515. https:\/\/doi.org\/10.2337\/diacare.24.3.510 (2001).","journal-title":"Diabetes Care"},{"issue":"7","key":"33011_CR34","doi-asserted-by":"publisher","first-page":"eabd6527","DOI":"10.1126\/sciadv.abd6527","volume":"24","author":"PS Apaolaza","year":"2021","unstructured":"Apaolaza, P. S. et al. NPOD-Virus Group. Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes. Sci. Adv. 24(7), eabd6527. https:\/\/doi.org\/10.1126\/sciadv.abd6527 (2021).","journal-title":"Sci. Adv."},{"key":"33011_CR35","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00125-013-3043-5","volume":"56","author":"ML Campbell-Thompson","year":"2013","unstructured":"Campbell-Thompson, M. L. et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56, 2541\u20132543. https:\/\/doi.org\/10.1007\/s00125-013-3043-5 (2013).","journal-title":"Diabetologia"},{"key":"33011_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0026-0495(93)90035-m","volume":"42","author":"K Nakanishi","year":"1993","unstructured":"Nakanishi, K. et al. Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism 42, 196\u2013203. https:\/\/doi.org\/10.1016\/0026-0495(93)90035-m (1993).","journal-title":"Metabolism"},{"key":"33011_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2337\/diacare.22.4.615","volume":"22","author":"A Shimada","year":"1999","unstructured":"Shimada, A. et al. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care 22, 615\u2013617. https:\/\/doi.org\/10.2337\/diacare.22.4.615 (1999).","journal-title":"Diabetes Care"},{"key":"33011_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1620\/tjem.125.185","volume":"125","author":"K Saito","year":"1978","unstructured":"Saito, K., Takahashi, T., Yaginuma, N. & Iwama, N. Islet morphometry in the diabetic pancreas of man. Tohoku J. Exp. Med. 125, 185\u2013197. https:\/\/doi.org\/10.1620\/tjem.125.185 (1978).","journal-title":"Tohoku J. Exp. Med."},{"key":"33011_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00125-013-3094-7","volume":"57","author":"SJ Richardson","year":"2014","unstructured":"Richardson, S. J. et al. Evaluation of the fidelity of immunolabelling obtained with clone 5D8\/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia 57, 392\u2013401. https:\/\/doi.org\/10.1007\/s00125-013-3094-7 (2014).","journal-title":"Diabetologia"},{"key":"33011_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jdi.13700","volume":"13","author":"E Jimbo","year":"2022","unstructured":"Jimbo, E. et al. Immunohistochemical detection of enterovirus in pancreatic tissues of patients with type 1 diabetes using a polyclonal antibody against 2A protease of Coxsackievirus. J. Diabetes Invest. 13, 435\u2013442. https:\/\/doi.org\/10.1111\/jdi.13700 (2022).","journal-title":"J. Diabetes Invest."},{"key":"33011_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s13340-020-00462-6","volume":"11","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T., Tanaka, S. & Aida, K. Unique pathological changes in the pancreas of fulminant type 1 diabetes. Diabetol. Int. 11, 323\u2013328. https:\/\/doi.org\/10.1007\/s13340-020-00462-6 (2020).","journal-title":"Diabetol. Int."},{"key":"33011_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. et al. Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719\u2013731. https:\/\/doi.org\/10.2337\/db15-0779 (2016).","journal-title":"Diabetes"},{"key":"33011_CR43","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/db09-0091","volume":"58","author":"S Tanaka","year":"2009","unstructured":"Tanaka, S. et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: A mechanism of accelerated \u03b2-cell failure in fulminant type 1 diabetes. Diabetes 58, 2285\u20132291. https:\/\/doi.org\/10.2337\/db09-0091 (2009).","journal-title":"Diabetes"},{"key":"33011_CR44","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2337\/db10-0795","volume":"60","author":"K Aida","year":"2011","unstructured":"Aida, K. et al. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates \u03b2-cell death in fulminant type 1 diabetes. Diabetes 60, 884\u2013889. https:\/\/doi.org\/10.2337\/db10-0795 (2011).","journal-title":"Diabetes"},{"key":"33011_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0009-8981(96)06422-4","volume":"256","author":"M Powell","year":"1996","unstructured":"Powell, M. et al. Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast. Clin. Chim. Acta 256, 175\u2013188. https:\/\/doi.org\/10.1016\/s0009-8981(96)06422-4 (1996).","journal-title":"Clin. Chim. Acta"},{"key":"33011_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2337\/diab.35.3.335","volume":"35","author":"T Kobayashi","year":"1986","unstructured":"Kobayashi, T. et al. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35, 335\u2013340. https:\/\/doi.org\/10.2337\/diab.35.3.335 (1986).","journal-title":"Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33011-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33011-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33011-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T08:11:25Z","timestamp":1682669485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33011-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33011"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33011-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6977"}}